Latest filing published 24 Jul 2026 for Rapid Micro Biosystems, INC., €1,107. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Richard S. Kollender (chief executive) discloses dealings in 2 companies, chiefly Rapid Micro Biosystems, Inc. and Strongbridge Biopharma plc. Over a trading history stretching from 17 May 2021 to 24 July 2026, the count stands at 11 filings.
No open-market sale appears; the market trades are 1 purchase worth €46k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 share grants and 2 option exercises.
The latest filing, published on 24 July 2026, reports an option exercise of €1,107 in Rapid Micro Biosystems, Inc. The clock since the last published purchase (7 August 2024) now reads 802 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations